| 2026年中报 | 2026年一季报 | 2025年年报 | 2025年中报 | 2025年一季报 | 2024年年报 | |
|---|---|---|---|---|---|---|
| 营业收入(元) | ||||||
| 己内酯(元) | 119,301,107.57 | 52,630,152.71 | 175,846,741.36 | 90,675,550.15 | - | 146,472,675.10 |
| 己内酯衍生物(元) | 264,739,846.12 | 146,825,729.57 | 451,684,765.23 | 218,058,741.06 | 105,896,684.08 | 325,528,876.03 |
| 副产品及其他(元) | 2,872,281.45 | 1,081,790.78 | 4,985,918.30 | 2,320,146.80 | 826,096.43 | 3,912,265.79 |
| 已内酯(元) | - | - | - | - | 45,841,202.58 | - |
| 营业成本(元) | ||||||
| 己内酯(元) | 66,262,508.55 | 30,886,534.47 | 107,533,278.01 | 57,214,111.88 | - | 99,372,331.39 |
| 己内酯衍生物(元) | 164,349,250.48 | 98,780,431.15 | 317,198,295.35 | 152,554,685.63 | 72,893,171.22 | 233,934,927.05 |
| 副产品及其他(元) | 2,091,612.68 | 702,149.86 | 3,967,876.76 | 2,079,886.68 | 1,156,063.72 | 5,699,670.36 |
| 已内酯(元) | - | - | - | - | 30,715,374.59 | - |
| 毛利(元) | ||||||
| 己内酯(元) | 53,038,599.02 | 21,743,618.24 | 68,313,463.35 | 33,461,438.27 | - | 47,100,343.71 |
| 己内酯衍生物(元) | 100,390,595.64 | 48,045,298.42 | 134,486,469.88 | 65,504,055.43 | 33,003,512.86 | 91,593,948.98 |
| 副产品及其他(元) | 780,668.77 | 379,640.92 | 1,018,041.54 | 240,260.12 | -329,967.29 | -1,787,404.57 |
| 已内酯(元) | - | - | - | - | 15,125,827.99 | - |
| 毛利率(%) | ||||||
| 己内酯(%) | 44.46 | 41.31 | 38.85 | 36.90 | - | 32.16 |
| 己内酯衍生物(%) | 37.92 | 32.72 | 29.77 | 30.04 | 31.17 | 28.14 |
| 副产品及其他(%) | 27.18 | 35.09 | 20.42 | 10.36 | -39.94 | -45.69 |
| 已内酯(%) | - | - | - | - | 33.00 | - |
| 收入构成(%) | ||||||
| 己内酯(%) | 30.83 | 26.24 | 27.80 | 29.15 | - | 30.78 |
| 己内酯衍生物(%) | 68.42 | 73.22 | 71.41 | 70.10 | 69.41 | 68.40 |
| 副产品及其他(%) | 0.74 | 0.54 | 0.79 | 0.75 | 0.54 | 0.82 |
| 已内酯(%) | - | - | - | - | 30.05 | - |
| 毛利构成(%) | ||||||
| 己内酯(%) | 34.39 | 30.99 | 33.52 | 33.73 | - | 34.40 |
| 己内酯衍生物(%) | 65.10 | 68.47 | 65.98 | 66.03 | 69.05 | 66.90 |
| 副产品及其他(%) | 0.51 | 0.54 | 0.50 | 0.24 | -0.69 | -1.31 |
| 已内酯(%) | - | - | - | - | 31.64 | - |